1. Home
  2. FITB vs HLN Comparison

FITB vs HLN Comparison

Compare FITB & HLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fifth Third Bancorp

FITB

Fifth Third Bancorp

HOLD

Current Price

$53.11

Market Cap

49.5B

Sector

Finance

ML Signal

HOLD

Logo Haleon plc (Each representing two)

HLN

Haleon plc (Each representing two)

BUY

Current Price

$9.28

Market Cap

42.8B

ML Signal

BUY

Company Overview

Basic Information
Metric
FITB
HLN
Founded
1858
2022
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Major Banks
Package Goods/Cosmetics
Sector
Finance
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
49.5B
42.8B
IPO Year
2009
2021

Fundamental Metrics

Financial Performance
Metric
FITB
HLN
Price
$53.11
$9.28
Analyst Decision
Buy
Buy
Analyst Count
16
1
Target Price
$55.13
N/A
AVG Volume (30 Days)
4.6M
12.5M
Earning Date
04-17-2026
02-26-2026
Dividend Yield
3.21%
1.94%
EPS Growth
12.42
N/A
EPS
1.02
N/A
Revenue
$577,000,000.00
N/A
Revenue This Year
$57.09
$6.55
Revenue Next Year
$7.06
$4.42
P/E Ratio
$52.23
$49.05
Revenue Growth
N/A
N/A
52 Week Low
$40.05
$8.65
52 Week High
$59.50
$11.28

Technical Indicators

Market Signals
Indicator
FITB
HLN
Relative Strength Index (RSI) 37.82 38.96
Support Level $52.61 $9.08
Resistance Level $53.33 $10.20
Average True Range (ATR) 1.08 0.15
MACD -0.09 -0.04
Stochastic Oscillator 35.01 17.73

Price Performance

Historical Comparison
FITB
HLN

About FITB Fifth Third Bancorp

Fifth Third Bancorp is a midsize regional bank in the US, with total assets of around $300 billion as of June 2026. The bank closed its acquisition of Comercia in February 2026. Headquartered in Cincinnati, Ohio, Fifth Third has a strong presence in the US Midwest and is currently expanding in the US Southeast. The bank provides a diversified set of financial services in retail banking, commercial banking, card and Treasury management, wealth and asset management, and capital markets.

About HLN Haleon plc (Each representing two)

Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.

Share on Social Networks: